These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34498698)

  • 1. Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations.
    Vansickel A; Baxter S; Sherwood N; Kong M; Campbell L
    Nicotine Tob Res; 2022 Feb; 24(3):295-305. PubMed ID: 34498698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conference on abuse liability and appeal of tobacco products: conclusions and recommendations.
    Henningfield JE; Hatsukami DK; Zeller M; Peters E
    Drug Alcohol Depend; 2011 Jul; 116(1-3):1-7. PubMed ID: 21376479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abuse liability assessment of tobacco products including potential reduced exposure products.
    Carter LP; Stitzer ML; Henningfield JE; O'Connor RJ; Cummings KM; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3241-62. PubMed ID: 19959676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consortium on Methods Evaluating Tobacco: Research Tools to Inform US Food and Drug Administration Regulation of Snus.
    Berman ML; Bickel WK; Harris AC; LeSage MG; O'Connor RJ; Stepanov I; Shields PG; Hatsukami DK
    Nicotine Tob Res; 2018 Sep; 20(11):1292-1300. PubMed ID: 29059363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abuse liability of two electronic nicotine delivery systems compared with combustible cigarettes and nicotine gum from an open-label randomized crossover study.
    Campbell C; Jin T; Round EK; Nelson PR; Baxter S
    Sci Rep; 2023 Nov; 13(1):18951. PubMed ID: 37919490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum.
    Stiles MF; Campbell LR; Jin T; Graff DW; Fant RV; Henningfield JE
    Psychopharmacology (Berl); 2018 Jul; 235(7):2077-2086. PubMed ID: 29725702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral Economic Laboratory Research in Tobacco Regulatory Science.
    Tidey JW; Cassidy RN; Miller ME; Smith TT
    Tob Regul Sci; 2016 Oct; 2(4):440-451. PubMed ID: 28580378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers.
    Goldenson NI; Buchhalter AR; Augustson EM; Rubinstein ML; Henningfield JE
    Drug Alcohol Depend; 2020 Dec; 217():108395. PubMed ID: 33176942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the Abuse Potential in Adult Smokers of a Novel Oral Tobacco Product Relative to Combustible Cigarettes and Nicotine Polacrilex Gum.
    Liu J; Wang J; Vansickel A; Edmiston J; Graff D; Sarkar M
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):241-250. PubMed ID: 33502815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models to assess the abuse liability of tobacco products: effects of smokeless tobacco extracts on intracranial self-stimulation.
    Harris AC; Tally L; Schmidt CE; Muelken P; Stepanov I; Saha S; Vogel RI; LeSage MG
    Drug Alcohol Depend; 2015 Feb; 147():60-7. PubMed ID: 25561387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tobacco and nicotine product testing.
    Hatsukami DK; Biener L; Leischow SJ; Zeller MR
    Nicotine Tob Res; 2012 Jan; 14(1):7-17. PubMed ID: 21460383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of harmful and potentially harmful constituents in the implementation of the 2009 US Family Smoking Prevention and Tobacco Control Act.
    Solyst J
    Drug Test Anal; 2023 Oct; 15(10):1198-1204. PubMed ID: 36094139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abuse liability assessment of the JUUL system in two nicotine concentrations compared to combustible cigarette, nicotine gum and comparator electronic nicotine delivery system.
    Goldenson NI; Buchhalter AR; Augustson EM; Rubinstein ML; Van Hoof D; Henningfield JE
    Drug Alcohol Depend; 2020 Dec; 217():108441. PubMed ID: 33250386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The First 10 Years: Reflecting on Opportunities and Challenges of the Tobacco Products Scientific Advisory Committee of the United States Food and Drug Administration.
    Fagan P; Eissenberg T; Jones DM; Cohen JE; Nez Henderson P; Clanton MS
    J Leg Med; 2020; 40(3-4):293-320. PubMed ID: 33797324
    [No Abstract]   [Full Text] [Related]  

  • 15. Basic Science and Public Policy: Informed Regulation for Nicotine and Tobacco Products.
    Fowler CD; Gipson CD; Kleykamp BA; Rupprecht LE; Harrell PT; Rees VW; Gould TJ; Oliver J; Bagdas D; Damaj MI; Schmidt HD; Duncan A; De Biasi M;
    Nicotine Tob Res; 2018 Jun; 20(7):789-799. PubMed ID: 29065200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical assessment of the scientific basis, and implementation, of regulations for the safety assessment and marketing of innovative tobacco-related products.
    Combes RD; Balls M
    Altern Lab Anim; 2015 Sep; 43(4):251-90. PubMed ID: 26375889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine Reduction Strategy: State of the science and challenges to tobacco control policy and FDA tobacco product regulation.
    Benowitz NL; Henningfield JE
    Prev Med; 2018 Dec; 117():5-7. PubMed ID: 29944901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmarketing surveillance for "modified-risk" tobacco products.
    O'Connor RJ
    Nicotine Tob Res; 2012 Jan; 14(1):29-42. PubMed ID: 21330282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability.
    Stiles MF; Campbell LR; Graff DW; Jones BA; Fant RV; Henningfield JE
    Psychopharmacology (Berl); 2017 Sep; 234(17):2643-2655. PubMed ID: 28634710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing modified risk tobacco and nicotine products: Description of the scientific framework and assessment of a closed modular electronic cigarette.
    Murphy J; Gaca M; Lowe F; Minet E; Breheny D; Prasad K; Camacho O; Fearon IM; Liu C; Wright C; McAdam K; Proctor C
    Regul Toxicol Pharmacol; 2017 Nov; 90():342-357. PubMed ID: 28954704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.